APA

Rodriguez R., Nademanee A., Palmer J. M., Parker P., Nakamura R., Snyder D., Pullarkat V., Zain J., Smith E., Sahebi F., Patane K., Senitzer D., Chang K. & Forman S. J. (20100323). Thymoglobulin, CYA and mycophenolate mofetil as GVHD prophylaxis for reduced-intensity unrelated donor hematopoietic cell transplantation: beneficial effect seen on chronic GVHD. : Bone marrow transplantation.

Chicago

Rodriguez R, Nademanee A, Palmer J M, Parker P, Nakamura R, Snyder D, Pullarkat V, Zain J, Smith E, Sahebi F, Patane K, Senitzer D, Chang K and Forman S J. 20100323. Thymoglobulin, CYA and mycophenolate mofetil as GVHD prophylaxis for reduced-intensity unrelated donor hematopoietic cell transplantation: beneficial effect seen on chronic GVHD. : Bone marrow transplantation.

Harvard

Rodriguez R., Nademanee A., Palmer J. M., Parker P., Nakamura R., Snyder D., Pullarkat V., Zain J., Smith E., Sahebi F., Patane K., Senitzer D., Chang K. and Forman S. J. (20100323). Thymoglobulin, CYA and mycophenolate mofetil as GVHD prophylaxis for reduced-intensity unrelated donor hematopoietic cell transplantation: beneficial effect seen on chronic GVHD. : Bone marrow transplantation.

MLA

Rodriguez R, Nademanee A, Palmer J M, Parker P, Nakamura R, Snyder D, Pullarkat V, Zain J, Smith E, Sahebi F, Patane K, Senitzer D, Chang K and Forman S J. Thymoglobulin, CYA and mycophenolate mofetil as GVHD prophylaxis for reduced-intensity unrelated donor hematopoietic cell transplantation: beneficial effect seen on chronic GVHD. : Bone marrow transplantation. 20100323.